Published in Oncogene on February 02, 1995
Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol Cell Biol (2000) 2.72
Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol (1999) 2.09
Regulation of Mdm2-directed degradation by the C terminus of p53. Mol Cell Biol (1998) 1.69
Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol Cell Biol (1998) 1.51
The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation. Mol Cell Biol (2001) 1.47
High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol (1996) 1.42
Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J Virol (2002) 1.19
Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin Microbiol Rev (1999) 1.14
Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription. J Virol (1996) 1.03
Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer (1998) 0.98
Proteasomal degradation of p53 by human papillomavirus E6 oncoprotein relies on the structural integrity of p53 core domain. PLoS One (2011) 0.89
HPV-p53-miR-34a axis in HPV-associated cancers. Ann Transl Med (2015) 0.78
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A (1999) 7.60
Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature (1987) 5.61
A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet (1999) 5.09
Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science (1990) 4.92
The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet (1997) 4.86
SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet (1998) 3.51
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet (2000) 3.41
Identification of the protein encoded by the E6 transforming gene of bovine papillomavirus. Science (1985) 3.21
Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J (1987) 2.84
Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci U S A (2000) 2.72
Acute aluminum phosphide poisoning--an epidemiological, clinical and histo-pathological study. J Assoc Physicians India (1988) 2.71
The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. EMBO J (1988) 2.66
An objective assessment of safety to drive in an upper limb cast. J Hand Surg Eur Vol (2012) 2.62
Bovine papilloma virus-transformed cells contain multiple E2 proteins. Proc Natl Acad Sci U S A (1988) 2.29
Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science (1995) 2.20
Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol (1999) 2.09
Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity. J Virol (1989) 1.64
Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 trans-activator. Genes Dev (1992) 1.49
Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J (1993) 1.49
Proteins encoded by the bovine papillomavirus E1 open reading frame: expression in heterologous systems and in virally transformed cells. J Virol (1990) 1.49
Relationships of physical activity with dietary behaviors among adults. Prev Med (2001) 1.48
Identification of an alpha helical motif sufficient for association with papillomavirus E6. J Biol Chem (1998) 1.45
The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene (2009) 1.45
The Working Healthy Project: a worksite health-promotion trial targeting physical activity, diet, and smoking. J Occup Environ Med (1999) 1.41
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther (2001) 1.37
Early physiologic predictors of injury severity and death in blunt multiple trauma. Arch Surg (1990) 1.36
The domain encoded by exon 2 of the survival motor neuron protein mediates nucleic acid binding. Hum Mol Genet (1998) 1.35
Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg (1997) 1.33
Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences. J Virol (1991) 1.32
AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J Virol (2000) 1.30
Mechanism of action of the papillomavirus E2 repressor: repression in the absence of DNA binding. J Virol (1992) 1.29
Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. EMBO J (1990) 1.27
Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J Virol (1996) 1.24
Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol Cell Biol (1997) 1.24
Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. J Mol Biol (1998) 1.23
Identification of survival motor neuron as a transcriptional activator-binding protein. Hum Mol Genet (1999) 1.22
X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol (1985) 1.21
The exon 2b region of the spinal muscular atrophy protein, SMN, is involved in self-association and SIP1 binding. Hum Mol Genet (2000) 1.21
Trans activation by the bovine papillomavirus E2 protein in Saccharomyces cerevisiae. J Virol (1989) 1.18
Genetic analysis of the bovine papillomavirus E2 transcriptional activation domain. Virology (1996) 1.15
Transcriptional activation function is not required for stimulation of DNA replication by bovine papillomavirus type 1 E2. J Virol (1996) 1.14
Tuberculosis risk among staff of a large public hospital in Kenya. Int J Tuberc Lung Dis (2008) 1.11
Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB. J Virol (1998) 1.08
Incorporating physical activity advice into primary care: physician-delivered advice within the activity counseling trial. Am J Prev Med (2000) 1.06
Mutational analysis of bovine papillomavirus E6 gene. J Virol (1989) 1.05
AMF1 (GPS2) modulates p53 transactivation. Mol Cell Biol (2001) 1.02
Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. Biochemistry (2001) 1.01
The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain (1993) 1.00
hAda3 regulates p14ARF-induced p53 acetylation and senescence. Oncogene (2007) 0.99
Specific inhibition of a human papillomavirus E2 trans-activator by intracellular delivery of its repressor. DNA Cell Biol (1994) 0.98
Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol (1995) 0.97
Cellular transformation by papillomavirus oncoproteins. Biochim Biophys Acta (1993) 0.96
Characterization of the pre-mRNA binding site for yeast ribosomal protein L32: the importance of a purine-rich internal loop. J Mol Biol (1995) 0.96
Human papillomavirus type 16 E6-enhanced susceptibility of L929 cells to tumor necrosis factor alpha correlates with increased accumulation of reactive oxygen species. J Biol Chem (1999) 0.94
Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Hum Mol Genet (2001) 0.94
High dose DBMC associated tolerance in live-related renal allograft recipients. Transplant Proc (2000) 0.93
A novel method for selective isotope labeling of bacterially expressed proteins. J Biomol NMR (1995) 0.92
Structural correlates for enhanced stability in the E2 DNA-binding domain from bovine papillomavirus. Biochemistry (1999) 0.90
Rotator cuff repair in patients over 70 years of age: early outcomes and risk factors associated with re-tear. Bone Joint J (2013) 0.88
The tryptophan bridge is a critical feature of the papillomavirus E2 DNA binding domain. Virology (1993) 0.88
The BPV-1 E2 DNA-contact helix cysteine is required for transcriptional activation but not replication in mammalian cells. Virology (1996) 0.88
In situ end labelling of DNA to detect apoptotic cell death in a variety of human tumours. Cell Death Differ (1994) 0.87
Lipid reactivity to stress: II. Biological and behavioral influences. Health Psychol (1999) 0.87
Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6. Virology (1997) 0.86
Novel in situ double labeling for simultaneous detection of proliferation and apoptosis. J Histochem Cytochem (1994) 0.86
Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease. Clin Exp Immunol (2012) 0.86
Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon. J Am Acad Dermatol (1984) 0.84
Effects of atenolol on exercise capacity in patients with mitral stenosis with sinus rhythm. Am J Cardiol (1985) 0.83
Papillomaviruses and interferon. Ciba Found Symp (1986) 0.83
Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg (1991) 0.82
Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol (1990) 0.81
Increased ouabain-sensitive glycolysis of lymphocytes treated with phytohemagglutinin: relationship to potassium transport. J Cell Physiol (1978) 0.81
Gross anatomy of the interphalangeal joint of the great toe: implications for excision of plantar capsular accessory ossicles. Clin Anat (2005) 0.81
1H, 15N, and 13C NMR resonance assignments for the DNA-binding domain of the BPV-1 E2 protein. J Biomol NMR (1998) 0.80
Two distinct regions of the BPV1 E1 replication protein interact with the activation domain of E2. Virus Res (1999) 0.80
Sequences flanking the core DNA-binding domain of bovine papillomavirus type 1 E2 contribute to DNA-binding function. J Virol (1997) 0.80
Papillomavirus-associated inductions of cellular proteins in mouse C127 cells: correlation with the presence of open reading frame E2. Virology (1989) 0.79
Mature cystic teratoma of the sigmoid colon. Ultrasound Obstet Gynecol (2011) 0.79
Postauricular fetal rhabdomyoma: light and electron microscopic study. Hum Pathol (1982) 0.78
Polyomavirus large T can support DNA replication in human cells. Virology (1998) 0.78
Prenatal ethanol exposure: susceptibility to convulsions and ethanol's anticonvulsant effect in amygdala-kindled rats. Alcohol Clin Exp Res (1994) 0.78
Effect of day length on cause of mortality, leg health, and ocular health in broilers. Poult Sci (2013) 0.77
Exercise, smoking cessation, and short-term changes in serum lipids in women: a preliminary investigation. Med Sci Sports Exerc (1998) 0.77
The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis. Oncogene (1999) 0.77
Training in exercise counseling. Acad Med (1994) 0.77
Rb-independent induction of apoptosis by bovine papillomavirus type 1 E7 in response to tumor necrosis factor alpha. J Biol Chem (2000) 0.77
Contingent drug tolerance: differential tolerance to the anticonvulsant, hypothermic, and ataxic effects of ethanol. Pharmacol Biochem Behav (1995) 0.76
The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody. Br J Haematol (1997) 0.76
Isolation, sequence analysis and characterization of a cDNA encoding human chaperonin 10. Biochim Biophys Acta (1994) 0.76
Cytomegalovirus infection in kidney transplantation: prophylaxis and management. Transplant Proc (1996) 0.76
Peri-vesical fat interposition flap reinforcement in high vesico-vaginal fistulas. J Surg Tech Case Rep (2010) 0.75
Digitalis-induced cardiac arrhythmias. An experimental study in dogs. Indian Heart J (1973) 0.75
An account of multiple casualties in an austere environment. J R Army Med Corps (2012) 0.75
Risk of cardiovascular disease among teachers in Cape Town: Findings of the South African PaCT pilot study. S Afr Med J (2016) 0.75
Tumor viruses, oncogenes, and human cancer. J Am Acad Dermatol (1984) 0.75
UV-B-energy distribution in phototherapy equipment. Arch Dermatol (1984) 0.75